Yasuaki Anami
- Oncology top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Molecular Biology
- Organic Chemistry
- Immunology
- Co-authors
- Kyoji TsuchikamaChisato M. YamazakiSummer Y.Y. HaNingyan ZhangZhiqiang AnWei XiongXun GuiAiko Yamaguchi
- Topics
- HER2/EGFR in Cancer Research (12 papers)Monoclonal and Polyclonal Antibodies Research (9 papers)Vitamin D Research Studies (7 papers)
- Partner nations
- United StatesJapanIndia
In The Last Decade
Yasuaki Anami
22 papers receiving 1000 citations
Hit Papers
Peers
Comparison fields: 5 of 71
- Oncology 592
- Radiology, Nuclear Medicine and Imaging 473
- Molecular Biology 365
- Organic Chemistry 124
- Immunology 88
Countries citing papers authored by Yasuaki Anami
This map shows the geographic impact of Yasuaki Anami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuaki Anami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuaki Anami more than expected).
Fields of papers citing papers by Yasuaki Anami
This network shows the impact of papers produced by Yasuaki Anami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuaki Anami. The network helps show where Yasuaki Anami may publish in the future.
Co-authorship network of co-authors of Yasuaki Anami
This figure shows the co-authorship network connecting the top 25 collaborators of Yasuaki Anami. A scholar is included among the top collaborators of Yasuaki Anami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuaki Anami. Yasuaki Anami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | Exploring the next generation of antibody–drug conjugatesbreakdown → | 276 |
| 3 | 5 | |
| 4 | 36 | |
| 5 | 36 | |
| 6 | 13 | |
| 7 | 16 | |
| 8 | Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistancebreakdown → | 210 |
| 9 | 1 | |
| 10 | 18 | |
| 11 | 42 | |
| 12 | 161 | |
| 13 | 23 | |
| 14 | 69 | |
| 15 | 11 | |
| 16 | 10 | |
| 17 | 21 | |
| 18 | 9 | |
| 19 | 6 | |
| 20 | 27 |
About Yasuaki Anami
Yasuaki Anami is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine, having authored 22 papers that have together received 1.0k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (12 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Vitamin D Research Studies (7 papers). The work is most often cited by research in Oncology (592 citations), Radiology, Nuclear Medicine and Imaging (473 citations) and Molecular Biology (365 citations). Yasuaki Anami has collaborated with scholars based in United States, Japan and India. Frequent co-authors include Kyoji Tsuchikama, Chisato M. Yamazaki, Summer Y.Y. Ha, Ningyan Zhang, Zhiqiang An, Wei Xiong, Xun Gui, Aiko Yamaguchi, Jangsoon Lee and Naoto T. Ueno. Their work appears in journals such as Journal of the American Chemical Society, Nature Communications and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.